Shanghai Serum Bio-Technology Co., Ltd.

SHSE:688163 Stock Report

Market Cap: CN¥1.6b

Shanghai Serum Bio-Technology Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure6.9yrs

Recent management updates

Recent updates


CEO

Shanghai Serum Bio-Technology has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Yiming He
Deputy GM & Director8.7yrsCN¥600.40k0.13%
CN¥ 2.0m
Yanping Jin
Supervisorno datano data0.065%
CN¥ 1.0m
Zhihe Fan
Chairman of the Board8.7yrsCN¥987.50k34.05%
CN¥ 536.1m
Lianzhong Zhu
Staff Supervisorno datano data0.046%
CN¥ 727.5k
Jie Zhou
Director5.1yrsno datano data
Jian Kang Zhang
Independent Director4.6yrsCN¥80.00kno data

6.9yrs

Average Tenure

65.5yo

Average Age

Experienced Board: 688163's board of directors are considered experienced (6.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.